BioSpace News Archive

Deals

Supernus Provides Business Update - March 30, 2020

Supernus Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, provides a business update related to the COVID-19 situation.

March 30, 2020
·
5 min read
Biotech Beach

Trade Show, Conference and Event Updates as of March 30, 2020

The following are updates to trade shows, conferences and events impacted by the novel coronavirus (COVID-19) pandemic.

March 30, 2020
·
3 min read
Deals

Exicure Provides Business Update Amid COVID-19 Pandemic

Exicure, Inc. provided an update on the Company’s operations in response to the global COVID-19 pandemic and the Company’s current evaluation of the impact the pandemic may have on the Company’s clinical trials, preclinical research and development and general business operations.

March 30, 2020
·
8 min read
Policy

Amarin Comments on Ruling in VASCEPA® ANDA Litigation

Amarin Corporation plc commented on the United States District Court for the District of Nevada’s ruling in favor of the generic companies in the company’s patent litigation against two filers of abbreviated new drug applications, or ANDAs, for Amarin’s VASCEPA® capsule franchise.

March 30, 2020
·
12 min read
Business

InterWell Health Appoints Co-Chief Medical Officers

George Hart, M.D. and Terry Ketchersid, M.D. to Lead Physician-driven Renal Population Health Management Company

March 30, 2020
·
3 min read
Business

AgeX Therapeutics Reports Fourth Quarter and Annual 2019 Financial Results and Provides Business Update

AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the fourth quarter and year-end results for 2019.

March 30, 2020
·
15 min read
Deals

Junshi Biosciences Announces Approval of Proposed A-Share Listing by the Listing Committee for the Shanghai Stock Exchange (SSE) STAR Market

Junshi Biosciences announced the approval of its proposed A-share listing by the Listing Committee for the Shanghai Stock Exchange STAR Market.

March 30, 2020
·
2 min read
Business

SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2019

SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a business update and announced its financial and operating results for the fourth quarter and full-year ended December 31, 2019.

March 30, 2020
·
20 min read